| Forearm compartment syndrome following thrombolytic therapy for acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 8070154 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Thrombolytic therapy for myocardial infarction may contribute to bleeding complications when central venous or arterial access is required, but peripheral venous access is usually uncomplicated. We report a patient in whom tissue plasminogen activator and subsequent intravenous heparin exacerbated bleeding from a disrupted intravenous access site, leading to acute compartment syndrome requiring surgical decompression. This case emphasizes the risks associated with iatrogenic trauma during thrombolytic therapy. |
| | |
Authors:
|
J Burnside; J M Costello; N J Angelastro; J Blankenship |
Related Documents
:
|
8141724 - Hirudin and hirulog. 9447334 - The gusto trial and the open artery theory. 10406064 - What an interventional cardiologist should know about the pharmacological treatment of ... 3521234 - Coronary thrombolytic therapy: state of the art. 1637734 - Recovery of myocardial function in the hibernating heart. 21295134 - Differential effect of nadph oxidase and xanthine oxidase inhibition on sympathetic rei... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Clinical cardiology Volume: 17 ISSN: 0160-9289 ISO Abbreviation: Clin Cardiol Publication Date: 1994 Jun |
Date Detail:
|
Created Date: 1994-09-23 Completed Date: 1994-09-23 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7903272 Medline TA: Clin Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 345-7 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Geisinger Medical Center, Danville, Pennsylvania 17822. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Compartment Syndromes
/
etiology* Forearm Humans Male Middle Aged Myocardial Infarction / drug therapy Thrombolytic Therapy / adverse effects* Tissue Plasminogen Activator / adverse effects |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Radiofrequency catheter ablation of both atrial ventricular nodal reentrant and atrial ventricular r...
Next Document: The Chronic Arthritis Systemic Index (CASI).